The $99 genetic test (added after your first month) analyzes peptide-pathway variants including GLP1R and GIPR, revealing your likely response pattern to semaglutide or tirzepatide
This represents the lower end of effective dosing for most applications
While the major uses for GLP-1s include those with type 2 diabetes and obesity, in March of 2024, the FDA also approved them for heart diseases
In just 2 short months, I am down 25 pounds and feel better than ever. What do I need to know about GLP
Why the cheaper drugs disappeared Manufactured by Novo Nordisk, Ozempic and Wegovy are once-a-week injectable medications
doi: 10.3389/fendo.2021.626427 Received 09 November 2020 Accepted 06 April 2021 Published 28 April 2021 Volume 12 - 2021 Edited by Nienke Biermasz, Leiden University, Netherlands Reviewed by Luiz Augusto Casulari, University of Brasilia, Brazil